LHC Group
LHCG
$169.81
Share price
0.00%
Change (1 day)
2.29%
Change (1 year)
Categories
P/S ratio for LHC Group (LHCG)
P/S ratio as of April 2024 (TTM): 2.32
According to LHC Group's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.31708. At the end of 2022 the company had a P/S ratio of 2.20.
P/S ratio history for LHC Group from 2005 to 2022
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2022 | 2.20 | 12.26% |
| 2021 | 1.96 | -40.05% |
| 2020 | 3.27 | 59.15% |
| 2019 | 2.05 | 28.98% |
| 2018 | 1.59 | 52.37% |
| 2017 | 1.04 | 15.01% |
| 2016 | 0.9080 | -6.19% |
| 2015 | 0.9680 | 31.79% |
| 2014 | 0.7345 | 17.56% |
| 2013 | 0.6248 | 10.49% |
| 2012 | 0.5655 | 48.53% |
| 2011 | 0.3807 | -55.67% |
| 2010 | 0.8588 | -24.39% |
| 2009 | 1.14 | -33.6% |
| 2008 | 1.71 | 15.31% |
| 2007 | 1.48 | -37.14% |
| 2006 | 2.36 | 32.9% |
| 2005 | 1.78 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Amedisys AMED | 1.33 | -42.77% | 🇺🇸 USA |
 National Healthcare
NHC | 1.19 | -48.80% | 🇺🇸 USA |
 Chemed CHE | 3.99 | 72.36% | 🇺🇸 USA |